Figure 1: Pharmaceutical Market, New Zealand, Revenue ($B and NZD), 2013-2020
Figure 2: Medical Device Market, New Zealand, Revenue ($B), 2015-2020
Figure 3: Healthcare Start-Ups in New Zealand, 2020
Figure 4: Country Profile, New Zealand, 2020
Figure 5: Pharmaceutical Market, New Zealand, Revenue ($B), 2011-2019
Figure 6: Pharmaceutical Market, New Zealand, Revenue Forecast ($B), 2020-2025
Figure 7: Focus Areas of Five-Year Action Plan of Ministry of Health, New Zealand, 2015-2020
Figure 8: Pharmaceutical Exports ($M), New Zealand, 2011-2020
Figure 9: Top Export Partners, New Zealand, 2020
Figure 10: Pharmaceutical Imports ($M), New Zealand, 2011-2020
Figure 11: Top Import Partners, New Zealand, 2020
Figure 12: Pharmaceutical Supply Channel, New Zealand, 2016
Figure 13: Medicine Supply Issue Management, PHARMAC, New Zealand, 2020
Figure 14: Generic Drugs Usage (% share by volume), New Zealand, 2010-2019
Figure 15: Generic Drugs Usage (% share by value), New Zealand, 2010-2019
Figure 16: OTC Market, New Zealand, Revenue ($M), 2013-2020
Figure 17: OTC Market by Drug Category, Revenue ($M), New Zealand, 2020
Figure 18: OTC Medicines Market, Major Distribution Channels ($M), New Zealand, 2020
Figure 19: Pharmaceutical Sales by Drug Category ($M), New Zealand, 2020
Figure 20: Major Therapeutic Areas by Pharmaceutical Sales ($M), New Zealand, 2017-2019
Figure 21: COVID-19 (Number of cases), New Zealand, 2020-2021
Figure 22: COVID-19 (Number of deaths), New Zealand, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, New Zealand, 2020-2021
Figure 24: COVID-19 Vaccine Administration, Number of Vaccines Administered, New Zealand, 2020-2021
Figure 25: Top COVID-19 Markets by Product Categories (Number of available marketed products), New Zealand, 2020-2021
Figure 26: Top COVID-19 IVD Products by Device Class (Number of available marketed products), New Zealand, 2020-2021
Figure 27: COVID-19 Clinical Trials Count by Phase, New Zealand, 2020-2021
Figure 28: COVID-19 Clinical Trials Count by Trial Status, New Zealand, 2020-2021
Figure 29: Medical Devices Market, New Zealand, Revenue ($B), 2015-2020
Figure 30: Medical Devices Market, New Zealand, Revenue Forecast ($B), 2021-2025
Figure 31: Medical Devices Market, New Zealand, Major Segments (%), 2020
Figure 32: Anesthesia & Respiratory Devices Market, New Zealand, Revenue ($M), 2015-2022
Figure 33: Anesthesia & Respiratory Devices Market, New Zealand, Market Share of Major Players (%), 2020
Figure 34: Orthopedic Devices Market, New Zealand, Revenue ($M), 2015-2022
Figure 35: Orthopedic Devices Market, New Zealand, Market Share of Major Players (%), 2020
Figure 36: General Surgery Devices Market, New Zealand, Revenue ($M), 2015-2022
Figure 37: General Surgery Devices Market, New Zealand, Market Share of Major Players (%), 2020
Figure 38: In Vitro Diagnostic Devices Market, New Zealand, Revenue ($M), 2015-2022
Figure 39: In Vitro Diagnostic Devices Market, New Zealand, Market Share of Major Players (%), 2020
Figure 40: Cardiovascular Devices Market, New Zealand, Revenue ($M), 2015-2022
Figure 41: Cardiovascular Devices Market, New Zealand, Market Share of Major Players (%), 2020
Figure 42: Diagnostic Market, New Zealand, Revenue ($M), 2015-2020
Figure 43: Diagnostic Market, New Zealand, Revenue Forecast ($M), 2021-2025
Figure 44: Medical Devices Market, New Zealand, Revenue ($B) of Major Companies, 2019
Figure 45: Deal Value and Deal Count, Pharmaceutical Market, New Zealand, 2019-2021
Figure 46: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, New Zealand, 2019-2021
Figure 47: Deal Value and Deal Count Subtypes, Pharmaceutical Market, New Zealand, 2019-2021
Figure 48: Top Therapy Areas by Deal Value, Pharmaceutical Market, New Zealand, 2019-2021
Figure 49: Mergers and Acquisitions by Quarter, Pharmaceutical Market, New Zealand, 2019-2021 (by value and by number)
Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, New Zealand, 2019-2021
Figure 51: Deal Value and Deal Count, Medical Devices Market, New Zealand, 2019-2021
Figure 52: Deal Value and Deal Count, Quarterly, Medical Devices Market, New Zealand, 2019-2021
Figure 53: Deal Value and Deal Count Subtypes, Medical Devices Market, New Zealand, 2019-2021
Figure 54: Top Equipment Sectors by Deal Value, Medical Devices Market, New Zealand, 2019-2021
Figure 55: Top Equipment Sectors by Deal Count, Medical Devices Market, New Zealand, 2019-2021
Figure 56: M&A Deals by Equipment Sector, Medical Devices Market, New Zealand, 2019-2021 (by value and by number)
Figure 57: Components of Digital Health Strategy, New Zealand, 2016-2020
Figure 58: Themes of Digital Health Strategy, New Zealand, 2018-2026
Figure 59: Digital Health Vision Focus Areas, New Zealand, 2018-2026
Figure 60: Deal Value ($M), HealthTech, New Zealand, 2019-2021
Figure 61: Deal Count (Number of Deals), HealthTech, New Zealand, 2019-2021
Figure 62: Principles for the Safe and Effective Use of Data and Analytics, New Zealand, 2018
Figure 63: Principles of Privacy Act 1993, New Zealand
Figure 64: Key Health Sector Organizations and People, New Zealand
Figure 65: Overview of Health System, New Zealand, 2020
Figure 66: PHARMAC Funding Criteria, New Zealand, 2020
Figure 67: Reimbursement Process, New Zealand, 2020
Figure 68: Private Health Insurance (% of total population), New Zealand, 2012-2019
Figure 69: Out-of-Pocket Spending (% of health spending), New Zealand, 2010-2018
Figure 70: Change in Pharmaceutical Price Index (2015 = 100), New Zealand, 2012-2020
Figure 71: Commercial Strategies Used by PHARMAC, New Zealand, 2020
Figure 72: Marketing Authorization for Pharmaceutical Products, New Zealand, 2019
Figure 73: Licensure of a Biosimilar Product, New Zealand, 2020
Figure 74: WAND Process for Medical Devices Approval, New Zealand, 2019
Figure 75: Patent Approval Process, New Zealand, 2019
Figure 76: Trademark Registration Process, New Zealand, 2019
Figure 77: Clinical Trial Approval Process, New Zealand, 2018
Figure 78: Pharmaceutical Clinical Trials Count by Trial Status, New Zealand, 2019-2021
Figure 79: Pharmaceutical Clinical Trials Count by Phase, New Zealand, 2019-2021
Figure 80: Pharmaceutical Clinical Trials Count by Indication, New Zealand, 2019-2021
Figure 81: Top Five Pharmaceutical Clinical Trials Sponsors by Count, New Zealand, 2019-2021
Figure 82: Medical Devices Clinical Trials Count by Trial Status, New Zealand, 2019-2021
Figure 83: Medical Devices Clinical Trials Count by Indication, New Zealand, 2019-2021
Figure 84: Medical Devices Clinical Trials Count by Device Category, New Zealand, 2019-2021
Figure 85: Top Five Medical Devices Clinical Trials Sponsors by Count, New Zealand, 2019-2021
Figure 86: Number of Hospitals (number), New Zealand, 2012-2019
Figure 87: Total Number of Diagnostic Equipment Units (number), New Zealand, 2012-2018
Figure 88: Number of Hospital Beds (per 1,000 Population), New Zealand, 2012-2019
Figure 89: Number of Acute Care Beds (per 1,000 Population), New Zealand, 2012-2019
Figure 90: Number of Psychiatric Care Beds (per 1,000 Population), New Zealand, 2012-2019
Figure 91: Life Expectancy at Birth (Years), New Zealand, 2012-2018
Figure 92: Immunization Rate (% of children immunized), New Zealand, 2012-2019
Figure 93: PM2.5 (µg per m3), New Zealand, 2012-2019
Figure 94: CO2 Emissions (Mt CO2), New Zealand, 2012-2019
Figure 95: Physicians (per 1,000 Population), New Zealand, 2012-2018
Figure 96: Dentists (per 1,000 Population), New Zealand, 2012-2018
Figure 97: Pharmacists (per 1,000 Population), New Zealand, 2012-2019
Figure 98: Nurses (per 1,000 Population), New Zealand, 2012-2018
Figure 99: Major Causes of Male Mortality (number of deaths), New Zealand, 2019
Figure 100: Major Causes of Mortality (number of deaths), New Zealand, 2019
Figure 101: Major Causes of Female Mortality (number of deaths), New Zealand, 2019
Figure 102: Disability-Adjusted Life Years by Major Disease (‘000), New Zealand, 2019
Figure 103: Healthcare Expenditure as Percentage of GDP (%), New Zealand, 2012-2019
Figure 104: Public-Private Share (%), New Zealand, 2012-2019
Figure 105: Opportunities and Challenges